Taichi Yabuno
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2026
Robotic versus laparoscopic rectal resection: impact on primary postoperative ileus and the role of intraoperative fluid balance: a propensity score-matched cohort study.
Journal: Surgical endoscopy
Published: March 25, 2026
Appendiceal Dieulafoy's Lesion: A Rare Cause of Lower Gastrointestinal Bleeding.
Journal: Surgical case reports
Published: December 12, 2025
Early Brain Metastasis despite Pathological Complete Response after Radical Resection for Esophageal Cancer following Chemotherapy and Pembrolizumab.
Journal: Surgical case reports
Published: July 28, 2025
Idiopathic Myointimal Hyperplasia of the Mesenteric Veins: Diagnosed After Resection due to Insufficient Palliative Surgery.
Journal: Surgical case reports
Published: March 12, 2025
Impact of Low Ligation on Bowel Perfusion and Anastomotic Leakage in Minimally Invasive Rectal Cancer Surgery: A Post Hoc Analysis of a Randomized Controlled Trial.
Journal: Diseases of the colon and rectum
Published: February 07, 2025
Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial.
Journal: Nature communications
Published: March 06, 2024
Blood Perfusion Assessment by Indocyanine Green Fluorescence Imaging for Minimally Invasive Rectal Cancer Surgery (EssentiAL trial): A Randomized Clinical Trial.
Journal: Annals of surgery
Published: May 23, 2023
Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
Journal: Cancer medicine
Published: July 18, 2020
Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
Journal: Cancer medicine
Published: September 20, 2019
Acute iliac arterial thrombosis during laparoscopic abdominoperineal resection.
Journal: Journal of surgical case reports
Published: November 15, 2018
Last Updated: 09/26/2026